Copertina

Identification of 2‐Substituted‐3‐Hydroxy‐2,3‐Dihydroquinazolin‐4(1 H ) Ones as Cell‐Active Inhibitors of KDM4A Lysine Demethylase

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Alessandra Feoli, Amodio Luca Balzano, Ida Pacilio, Alessandra Cipriano, Roman Belle, Giacomo Pepe, Manuela Giovanna Basilicata, Pietro Campiglia, Fabrizio Micheli, Akane Kawamura, Ciro Milite, Sabrina Castellano, Axel Imhof, Gianluca Sbardella
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2026
Soggetti:	ChemMedChem
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery
di: Ilaria Cursaro, et al.
Pubblicazione: (2024)

A Novel Synthetic Route for Lysine‐Specific Demethylase 1‐Targeting Compounds: CC‐90011 and MS9117
di: Jingying Wang, et al.
Pubblicazione: (2026)

AMPK Activation by 2′‐Hydroxy‐2,4,5‐Trimethoxychalcone Derivatives in Podocyte Cells
di: Vu‐Duy Nguyen, et al.
Pubblicazione: (2025)

Exploring 6‐Hydroxy‐3‐Aryl/Heteroarylcoumarins as Promising Candidates Against Trypanosoma cruzi
di: C. N. Pereira, et al.
Pubblicazione: (2026)

Development of C646‐Based Proteolysis Targeting Chimeras Degraders of the Lysine Acetyltransferases CBP and p300
di: Francesco Fiorentino, et al.
Pubblicazione: (2025)

Synthesis and Biological Characterization of 4,4‐Difluoro‐3‐(phenoxymethyl)piperidine Scaffold as Dopamine 4 Receptor (D 4 R) Antagonist in vitro Tool compounds
di: Saeedeh Saeedi, et al.
Pubblicazione: (2025)

Structural Impact of 4‐Hydroxynonenal Modification on Human Cytochrome CYP4F11
di: Olena Gnatyuk, et al.
Pubblicazione: (2026)

Inhibition of polymorphic MexXY‐OprM efflux system in Pseudomonas aeruginosa clinical isolates by Berberine derivatives
di: Giorgia Giorgini, et al.
Pubblicazione: (2024)

Identification of a New Interesting BAG3 Modulator Able to Disrupt Cancer‐Related Pathways
di: Dafne Ruggiero, et al.
Pubblicazione: (2025)

Design, Synthesis, and Xanthine Oxidase Inhibitory Activity of 4‐(5‐Aminosubstituted‐4‐cyanooxazol‐2‐yl)benzoic Acids
di: Oleksandr Kobzar, et al.
Pubblicazione: (2024)

Improving Affinity while Reducing Kidney Uptake of CXCR4‐Targeting Radioligands Derived from the Endogenous Antagonist EPI‐X4
di: Raghuvir H. Gaonkar, et al.
Pubblicazione: (2025)

The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead
di: Jean Quancard, et al.
Pubblicazione: (2025)

Cover Feature: The European Federation for Medicinal Chemistry and Chemical Biology (EFMC) Best Practice Initiative: Hit to Lead (ChemMedChem 8/2025)
di: Jean Quancard, et al.
Pubblicazione: (2025)

Identification of Novel and Selective GPR39 Receptor Antagonists for the Treatment of Acute Myocardial Ischemia
di: Agostino Cianciulli, et al.
Pubblicazione: (2025)

Biaryl Phosphate‐Based Inhibitors of the Transcription Factor STAT4
di: Nadiya Brovchenko, et al.
Pubblicazione: (2025)

Substituted Benzylidene‐3‐Oxo‐3,4‐Dihydro‐2 H ‐Benzo[ b ][1,4]thiazine‐6‐Carboxylic Acid Analogs as Dynamin GTPase Inhibitors
di: Andrew J. S. Lin, et al.
Pubblicazione: (2025)

Acetic Acid‐Driven One‐Pot Synthesis of 4,7‐dihydro‐[1,2,3]thiadiazolo[5,4‐b]pyridine‐6‐carboxamides and Pharmacological Evaluations
di: Savan S Bhalodiya, et al.
Pubblicazione: (2024)

Cover Feature: Improving Affinity while Reducing Kidney Uptake of CXCR4‐Targeting Radioligands Derived from the Endogenous Antagonist EPI‐X4 (ChemMedChem 6/2025)
di: Raghuvir H. Gaonkar, et al.
Pubblicazione: (2025)

Cover Feature: Design, Synthesis, and Anti‐Prostate Cancer Potential of 2‐(4‐Nitrobenzyl) Malonates In Vitro and DAL Acute Oral Toxicity Assessment In Vivo (ChemMedChem 4/2025)
di: Bharathi Hassan Ganesh, et al.
Pubblicazione: (2025)

4‐Aza Cyclopentenone Prostaglandin Analogues: Synthesis and NF‐κB Inhibitory Activities
di: William Doherty, et al.
Pubblicazione: (2024)

Fluorescence Detection of DNA/RNA G‐Quadruplexes (G4s) by Twice‐as‐Smart Ligands
di: Jiri Ledvinka, et al.
Pubblicazione: (2025)

Ligand‐Induced Conformational Plasticity of the CTLH E3 Ligase Receptor GID4
di: Daria Kotlarek, et al.
Pubblicazione: (2026)

Pantinin‐Derived Peptides against Veterinary Herpesviruses: Activity and Structural Characterization
di: Rosa Giugliano, et al.
Pubblicazione: (2025)

In Vitro and In Vivo Biological Evaluation of Novel 1,4‐Naphthoquinone Derivatives as Potential Anticancer Agents
di: Palanisamy Ravichandiran, et al.
Pubblicazione: (2024)

Beyond the Toll‐Like Receptor 4. Structure‐Dependent Lipopolysaccharide Recognition Systems: How far are we?
di: Stefania De Chiara, et al.
Pubblicazione: (2025)

Development of Styryl‐Modified 3,4‐Dihydropyrimidin‐2(1 H )‐ones as Potential Antitumor Agents
di: Konstantinos Panagoulias, et al.
Pubblicazione: (2026)

Lactam Truncation Yields a Dihydroquinazolinone Scaffold with Potent Antimalarial Activity that Targets PfATP4
di: Trent D. Ashton, et al.
Pubblicazione: (2024)

Synthesis and Antifungal Activity of 4‐Arylamino‐1,2‐Naphthoquinones‐1,2,3‐Triazoles Hybrids
di: Acácio Silva de Souza, et al.
Pubblicazione: (2026)

Novel 4,5‐Dihydrothiazole‐Phenylpiperazine Derivatives: Synthesis, Docking Studies and Pharmacological Evaluation as Serotonergic Agents
di: Giorgia Andreozzi, et al.
Pubblicazione: (2025)

4‐(5‐Chloro‐3‐(3,4,5‐trimethoxybenzoyl)‐1 H ‐indol‐1‐yl)benzenesulfonamide: A Novel Polypharmacology Agent to Target Carbonic Anhydrase IX and XII With Improved Selectivity, Wnt/β‐Catenin Signaling Pathway, and P‐Glycoprotein
di: Michela Puxeddu, et al.
Pubblicazione: (2026)

Front Cover: Functional Proteomics of Quinazolin‐4‐One Derivatives Targeting the Proteasome (ChemMedChem 2/2026)
di: Elva Morretta, et al.
Pubblicazione: (2026)

One‐Step Assembly of Homogeneous DAR4 ADCs via a Traceless Fc Ligand‐Directed Acylation Strategy
di: Yue Zeng, et al.
Pubblicazione: (2026)

Synthesis, Biological Evaluation, and Interaction with Calf Thymus‐DNA of Mono‐ and Diamidino‐Substituted Imidazo[4,5‐ b ]pyridines
di: Ida Boček Pavlinac, et al.
Pubblicazione: (2025)

Design, Synthesis, and In Vitro and In Silico Evaluation of 1,3,4‐Oxadiazoles as Anti‐Trypanosoma cruzi and Anti‐Leishmania mexicana Agents
di: Timoteo Delgado‐Maldonado, et al.
Pubblicazione: (2024)

New Indole‐Based Phenylthiazolyl‐2,4‐dihydropyrazolones as Tubulin polymerization inhibitors: Multicomponent Synthesis, Cytotoxicity Evaluation, and in silico Studies
di: Bulti Bakchi, et al.
Pubblicazione: (2024)

Insights into the Overcoming EGFRDel19/T790M/C797S Mutation: A Perspective on the 2‐Aryl‐4‐aminothienopyrimidine Backbone
di: Xuan Zhang, et al.
Pubblicazione: (2024)

Synthesis, Characterization, and Biological Activity of New 4‘‐Functionalized Bis‐Terpyridine Ruthenium(II) Complexes: Anti‐Inflammatory Activity Advances
di: Mohamed M. Elnagar, et al.
Pubblicazione: (2024)

Design and Synthesis of Pyrimidino[4,5‐ d ]Pyrimidine‐Based Compounds as Potent B‐RAF V600E Inhibitors
di: Eleftheria A. Georgiou, et al.
Pubblicazione: (2026)

3′‐Dehydroxypurpurogallin‐4‐Carboxamides as Influenza A Endonuclease Inhibitors: Synthesis, Structure–Activity Relationship Analysis, and Structural Characterization of Protein Complex
di: Michal Kráľ, et al.
Pubblicazione: (2025)

Towards the Use of Metabolic Volatiles in Breath for Determining Drug Response: Gstachamine as an Unlabeled Substrate to Measure CYP3A4 Activity
di: Valentina Stock, et al.
Pubblicazione: (2025)